
Loading, please wait...

Loading, please wait...

South Asian women face a significantly higher risk of experiencing premature menopause.
This critical finding comes from a multi-country analysis published in The Lancet journal.
Consequently, clinicians must recognize how this early transition impacts future female health.
Specifically, early hormonal decline closely correlates with a higher risk of cardiovascular events.
Indeed, reaching menopause before the age of 40 is clinically defined as premature menopause.
In addition, menopause occurring between ages 40 and 44 is categorized as early menopause.
According to the PURE study, younger menopause ages elevate the risk of stroke or heart attacks.
Furthermore, premature menopause increases cardiovascular risk by 27 percent.
Similarly, early menopause is associated with a 14 percent risk elevation.
Therefore, these age thresholds serve as crucial clinical indicators for cardiovascular risk assessment in female patients.
Notably, the study evaluated over 111,000 women across 26 countries.
The data revealed that women in lower-income countries experience premature menopause at a much higher rate.
For instance, their median menopausal age is 47.5 years compared to 50.6 years in wealthier countries.
Moreover, South Asian women experience menopause at a median age of 47.4 years.
This represents a 34 percent increased risk of premature menopause compared to European women.
However, traditional risk factors like obesity and hypertension do not fully explain this elevated risk.
Thus, clinicians must look beyond traditional metrics when assessing South Asian patients.
Q1: What defines premature menopause and early menopause?
Premature menopause is defined as reaching menopause before the age of 40. In contrast, early menopause occurs when a woman experiences menopause between the ages of 40 and 44.
Q2: Why does premature menopause increase cardiovascular risk?
Earlier menopause reduces the duration of natural estrogen exposure. Consequently, this hormonal decline can lead to early vascular aging, increasing the risk of stroke and heart attack.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A landmark global study reveals that South Asian women experience premature menopause at a significantly higher rate compared to European women. This earlier hormonal transition acts as an independent marker for heightened cardiovascular risks, including stroke and myocardial infarction.
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today